Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

BACKGROUND: Limited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in solid cancer patients. We aimed to assess the immunogenicity of the ChAdOx1-nCoV-19 vaccine and the impact of different anticancer therapies for s...

Descripción completa

Detalles Bibliográficos
Autores principales: Teeyapun, Nattaya, Luangdilok, Sutima, Pakvisal, Nussara, Sainamthip, Panot, Mingmalairak, Siyamol, Poovorawan, Nattaya, Sitthideatphaiboon, Piyada, Parinyanitikul, Napa, Sriuranpong, Virote, Namkanisorn, Teerayuth, Inthasuwan, Pratchaya, Angspatt, Pattama, Wongchanapat, Ploytuangporn, Bamrungnam, Akradach, Leeleakpai, Nutchanok, Uttha, Sutheera, Jaichum, Supaporn, Kongkaew, Peerawich, Suksanong, Chayanin, Veranitinun, Rattiya, Prasomphol, Ampai, Sartsuk, Chada, Patcharajutanon, Cheeraporn, Preaprang, Supreeya, Choengsamor, Hathairat, Phongwan, Rungthong, Preeyasaksa, Charoenpit, Phaibulvatanapong, Ekkamol, Suntronwong, Nungruthai, Yorsaeng, Ritthideach, Vichaiwattana, Preeyaporn, Wanlapakorn, Nasamon, Kerr, Stephen J., Poovorawan, Yong, Wanchaijiraboon, Passakorn, Tanasanvimon, Suebpong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366110/
https://www.ncbi.nlm.nih.gov/pubmed/35971500
http://dx.doi.org/10.1016/j.eclinm.2022.101608

Ejemplares similares

Ejemplares similares